Civic Intelligence

Global Hiv Vaccine Enterprise

990 • Fiscal year 2014 • EIN 20-3347314

Jan 01, 2014 to Dec 31, 2014

Organization Profilewww.vaccineenterprise.org
Brooklyn, NY
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

53rd percentile

0.22x

Higher debt load relative to assets than 53% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2014

Liabilities / Revenue

54th percentile

0.22x

Higher debt load relative to revenue than 54% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2014

Net Margin

78th percentile

20%

Higher net margin than 78% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2014

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2014

Asset Growth

94th percentile

58%

Faster asset growth than 94% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2013 to 2014

Revenue Growth

92nd percentile

75%

Faster revenue growth than 92% of similar nonprofits.

2014 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2013 to 2014

Balance Sheet
Liabilities / Assets53rd percentile

Assets

Up

$5,918,954

Up $2,163,521 (+58%) from 2013

Net Assets

Up

$4,607,220

Up $1,147,592 (+33%) from 2013

Liabilities

Up

$1,311,734

Up $1,015,929 (+343%) from 2013

Revenue And Expenses
Liabilities / Revenue54th percentileNet Margin78th percentile

Revenue

Up

$5,878,271

Up $2,513,815 (+75%) from 2013

Expenses

Up

$4,730,679

Up $566,234 (+14%) from 2013

Net Income

Up

$1,147,592

Up $1,947,581 (+243%) from 2013

Historical Trend

Balance Sheet Trend

Asset Growth94th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$8.0M$6.0M$4.0M$2.0M$0Assets 2010: $6,522,922Liabilities 2010: $180,467Net Assets 2010: $6,342,4552010Assets 2011: $4,063,293Liabilities 2011: $143,908Net Assets 2011: $3,919,3852011Assets 2012: $4,512,811Liabilities 2012: $253,194Net Assets 2012: $4,259,6172012Assets 2013: $3,755,433Liabilities 2013: $295,805Net Assets 2013: $3,459,6282013Assets 2014: $5,918,954Liabilities 2014: $1,311,734Net Assets 2014: $4,607,2202014Assets 2015: $4,677,175Liabilities 2015: $815,408Net Assets 2015: $3,861,7672015Assets 2016: $4,450,065Liabilities 2016: $624,036Net Assets 2016: $3,826,0292016Assets 2017: $2,976,032Liabilities 2017: $1,687,764Net Assets 2017: $1,288,2682017

Highlighted filing

2014

Assets$5,918,954
Liabilities$1,311,734
Net Assets$4,607,220
Open 2014 Filing

Operations Trend

Revenue Growth92nd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$10M$5.0M$0-$5.0MRevenue 2010: $2,609,734Expenses 2010: $5,296,628Net Income 2010: -$2,686,8942010Revenue 2011: $2,246,515Expenses 2011: $4,669,809Net Income 2011: -$2,423,2942011Revenue 2012: $3,682,982Expenses 2012: $3,342,750Net Income 2012: $340,2322012Revenue 2013: $3,364,456Expenses 2013: $4,164,445Net Income 2013: -$799,9892013Revenue 2014: $5,878,271Expenses 2014: $4,730,679Net Income 2014: $1,147,5922014Revenue 2015: $2,095,581Expenses 2015: $2,841,034Net Income 2015: -$745,4532015Revenue 2016: $4,926,868Expenses 2016: $4,870,631Net Income 2016: $56,2372016Revenue 2017: $1,160,530Expenses 2017: $3,698,291Net Income 2017: -$2,537,7612017

Highlighted filing

2014

Revenue$5,878,271
Expenses$4,730,679
Net Income$1,147,592
Open 2014 Filing
Filing Detail Status

This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2017)
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Mission and Program Overview

Mission

The global hiv vaccine enterprise (the enterprise) is an alliance of independent organizations dedicated to accelerating the development of safe and effective hiv vaccines for use globally. It moves vaccine research and development forward among organizations through coordination, collaboration, knowledge-sharing and efforts to attract interest, resources and funders to the field. Since 2014, the enterprise has hosted the successful, new, biennial hiv research for prevention (hivr4p) conference. Hivr4p, the worlds only scientific meeting dedicated exclusively to biomedical hiv prevention research, brings together policy experts, funders, stakeholders and others to share and discuss the latest scientific developments from all hiv prevention disciplines and approaches, including their distinctive features, commonalities and combination.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2014 • Form 990Summary only. Only limited summary data is available for this year.

Open filing
Assets
$5,918,954
Liabilities
$1,311,734
Net assets
$4,607,220
Revenue
$5,878,271
Expenses
$4,730,679
Net income
$1,147,592
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2017Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.98$1.69$1.29$1.16$3.70$2.54
2016Summary only. Only limited summary data is available for this year.$4.45$0.62$3.83$4.93$4.87$0.06
2015Summary only. Only limited summary data is available for this year.$4.68$0.82$3.86$2.10$2.84$0.75
2014Summary only. Only limited summary data is available for this year.$5.92$1.31$4.61$5.88$4.73$1.15
2013Summary only. Only limited summary data is available for this year.$3.76$0.30$3.46$3.36$4.16$0.80
2012Summary only. Only limited summary data is available for this year.$4.51$0.25$4.26$3.68$3.34$0.34
2011Summary only. Only limited summary data is available for this year.$4.06$0.14$3.92$2.25$4.67$2.42
2010Summary only. Only limited summary data is available for this year.$6.52$0.18$6.34$2.61$5.30$2.69